Growth-suppressing function of glypican-3 (GPC3) via insulin like growth factor II (IGF-II) signaling pathway in ovarian clear cell carcinoma cells

Gynecologic Oncology

Volumn 119, Issue 2, 2010, Pages 332-336

  Sakurai, Maiko ^a   Shibata, Kiyosumi ^a   Umezu, Tomokazu ^a   Kajiyama, Hiroaki ^a   Yamamoto, Eiko ^a   Ino, Kazuhiko ^a   Nawa, Akihiro ^a   Kikkawa, Fumitaka ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Cell growth; Glypican 3 (GPC3); Insulin like growth factor II (IGF II); Ovarian clear cell carcinoma

Indexed keywords

GLYPICAN 3; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SHORT HAIRPIN RNA; SOMATOMEDIN B; WORTMANNIN; GLYPICAN; GPC3 PROTEIN, HUMAN; SMALL INTERFERING RNA;

ARTICLE; CELL GROWTH; CLEAR CELL CARCINOMA; COLONY FORMATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; OVARY CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; ADENOCARCINOMA; BIOSYNTHESIS; CANCER STEM CELL; FEMALE; GENE SILENCING; GENETIC TRANSFECTION; GENETICS; IMMUNOHISTOCHEMISTRY; METABOLISM; OVARY TUMOR; PATHOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ADENOCARCINOMA, CLEAR CELL; CELL GROWTH PROCESSES; CELL LINE, TUMOR; FEMALE; GENE KNOCKDOWN TECHNIQUES; GLYPICANS; HUMANS; IMMUNOHISTOCHEMISTRY; INSULIN-LIKE GROWTH FACTOR II; NEOPLASTIC STEM CELLS; OVARIAN NEOPLASMS; PROTO-ONCOGENE PROTEINS C-AKT; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TRANSFECTION; PHOSPHATIDYLINOSITOL 3-KINASES;

EID: 77957754116     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2010.07.013     Document Type: Article

References (26)

1. F.O. Recio, M.S. Piver, R.E. Hempling, and D.L. Driscoll Lack of improved survival plus increase in thromboembolic complications in patients with clear cell carcinoma of the ovary treated with platinum versus nonplatinum-based chemotherapy Cancer 78 1996 2157 2163
2. T. Sugiyama, T. Kamura, J. Kigawa, N. Terakawa, Y. Kikuchi, and T. Kita Clinical characteristics of clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy Cancer 88 2000 2584 2589
3. J. Filmus, and S.B. Selleck Glypicans: proteoglycans with a surprise J Clin Invest 108 2001 497 501
4. H.L. Wang, F. Anatelli, Q.J. Zhai, B. Adley, S.T. Chuang, and X.J. Yang Glypican-3 as a useful diagnostic marker that distinguishes hepatocellular carcinoma from benign hepatocellular mass lesions Arch Pathol Lab Med 132 11 2008 1723 1728
5. M.I. Capurro, Y.Y. Xiang, C. Lobe, and J. Filmus Glypican-3 promotes the growth of hepatocellular carcinoma by stimulating canonical Wnt signaling Cancer Res 65 14 2005 6245 6254
6. J.A. Toretsky, N.L. Zitomersky, A.E. Eskenazi, R.W. Voigt, E.D. Strauch, and C.C. Sun Glypican-3 expression in Wilms tumor and hepatoblastoma J Pediatr Hematol Oncol 23 8 2001 496 499
7. T. Nakatsura, T. Kageshita, S. Ito, K. Wakamatsu, M. Monji, and Y. Ikuta Identification of glypican-3 as a novel tumor marker for melanoma Clin Cancer Res 10 19 2004 6612 6621
8. D. Maeda, S. Ota, Y. Takazawa, H. Aburatani, S. Nakagawa, and T. Yano Glypican-3 expression in clear cell adenocarcinoma of the ovary Mod Pathol 22 6 2009 824 832
9. D.L. Zynger, N.D. Dimov, C. Luan, B.T. Teh, and X.J. Yang Glypican 3: a novel marker in testicular germ cell tumors Am J Surg Pathol 30 12 2006 1570 1575
10. G. Plia, R.M. Hughes-Benzie, A. Mackenzie, P. Baybayan, E.Y. Chen, and R. Huber Mutations in GPC3, a glypican gene, cause the Simpson-Golabi-Behmel overgrowth syndrome Nat Genet 12 3 1996 241 247
11. Y. Xu, A. Papageorgiou, and C. Polychronakos Developmental regulation of the soluble form of insulin-like growth factor-II/mannose 6-phosphate receptor in human serum and amniotic fluid J Clin Endocrinol Metab 83 2 1998 437 442
12. Z. Pietrzkowski, G. Mulholland, L. Gomella, B.A. Jameson, D. Wernicke, and R. Baserga Inhibition of growth of prostatic cancer cell lines by peptide analogues of insulin-like growth factor 1 Cancer Res 53 5 1993 1102 1106
13. M. Resnicoff, D. Abraham, W. Yutanawiboonchai, H.L. Rotman, J. Kajstura, and R. Rubin The insulin-like growth factor I receptor protects tumor cells from apoptosis in vivo Cancer Res 55 11 1995 2463 2469
14. R.M. Hughes-Benzie, G. Pilia, J.Y. Xuan, A.G. Hunter, E. Chen, and M. Golabi Simpson-Golabi-Behmel syndrome: genotype/phenotype analysis of 18 affected males from 7 unrelated families Am J Med Genet 11 1996 227 234
15. Y.K. Sung, S.Y. Hwang, M. Farooq, J.C. Kim, and M.K. Kim Growth promotion of HepG2 hepatoma cells by antisense-mediated knockdown of glypican-3 is independent of insulin-like growth factor 2 signaling Exp Mol Med 35 4 2003 257 262
16. W. Cheng, C.J. Tseng, T.T. Lin, I. Cheng, H.W. Pan, and H.C. Hsu Glypican-3-mediated oncogenesis involves the insulin-like growth factor-signaling pathway Carcinogenesis 29 7 2008 1319 1326
17. C.M. Ho, Y.J. Huang, T.C. Chen, S.H. Huang, F.S. Liu, and C.C. Chang Chien Pure-type clear cell carcinoma of the ovary as a distinct histological type and improved survival in patients treated with paclitaxel-platinum-based chemotherapy in pure-type advanced disease Gynecol Oncol 94 1 Jul 2004 197 203
18. M. Mizuno, F. Kikkawa, K. Shibata, H. Kajiyama, K. Ino, and M. Kawai Long-term follow-up and prognostic factor analysis in clear cell adenocarcinoma of the ovary J Surg Oncol 94 2 Aug 1 2006 138 143
19. M. Takano, T. Sugiyama, N. Yaegashi, M. Suzuki, H. Tsuda, and S. Sagae The impact of complete surgical staging upon survival in early-stage ovarian clear cell carcinoma: a multi-institutional retrospective study Int J Gynecol Cancer 19 8 2009 1353 1357
20. D. Pectasides, G. Fountzilas, G. Aravantinos, C. Kalofonos, H. Efstathiou, and D. Farmakis Advanced stage clear-cell epithelial ovarian cancer: the Hellenic Cooperative Oncology Group experience Gynecol Oncol 102 2 2006 285 291
21. K. Yun, M. Fukumoto, and Y. Jinno Monoallelic expression of the insulin-like growth factor-2 gene in ovarian cancer Am J Pathol 148 4 1996 1081 1087
22. H. Werner, and D. LeRoith The role of the insulin-like growth factor system in human cancer Adv Cancer Res 68 1996 183 223
23. W. Cheng, C.J. Tseng, T.T. Lin, I. Cheng, H.W. Pan, and H.C. Hsu Glypican-3-mediated oncogenesis involves the Insulin-like growth factor-signaling pathway Carcinogenesis 29 7 2008 1319 1326
24. S.I. Zittermann, M.I. Capurro, W. Shi, and J. Filmus Soluble glypican 3 inhibits the growth of hepatocellular carcinoma in vitro and in vivo Int J Cancer 126 6 2010 1291 1301
25. T. Umezu, K. Shibata, M. Shimaoka, H. Kajiyama, E. Yamamoto, and K. Ino Gene silencing of glypican-3 in clear cell carcinoma of the ovary renders it more sensitive to the apoptotic agent paclitaxel in vitro and in vivo Cancer Sci 101 1 2010 143 148
26. H.H. Song, W. Shi, Y.Y. Xiang, and J. Filmus The loss of glypican-3 induces alterations in Wnt signaling J Biol Chem 280 3 2005 2116 2125